NFYB and hepatocellular carcinoma: The results showed that NFYB expression was significantly higher in Cholangiocarcinoma (CHOL), colon cancer, esophageal cancer, head and neck cancer, hepatocellular carcinoma, and gastric cancer than in adjacent normal tissues.